HDFC Securities Institutional Equities

HDFC Securities has reviewed the second-quarter earnings across pharma and metal sector including Divi's Laboratories and Tata Steel.

Following September-quarter earnings, HDFC Sec has maintained its postive stance on 15 stocks across ports, including LIC, Apollo Hospitals, Titan Company, Aurobinod Pharma, Ipca Labs, and more.

Following September-quarter earnings, HDFC Sec has maintained its ratings on 17 stocks across pharma, capital markets, financial services, healthcare, retail, chemicals, including Zydus Life, BSE, Nykaa, Lupin, MCX, Sundaram Finance, HG Infra and more.

Clear strategic actions under the new leadership will be critical to sustaining the early momentum and supporting Dabur's valuation recovery, says the brokerage.

Based on HDFC Securities' target prices and closing prices, Eureka Forbes offers the highest potential upside of about 67%among the covered stocks, followed by SBI with 35% and , BEL with 30% and KEC International's target price implies a potential upside of 19%.

The brokerage's latest assessment reflects a mixed earnings season, with healthy growth, improving operating performance and business expansion supporting some companies, while margin pressures, subdued demand and regulatory concerns continue to weigh on others.

A refined strategy anchored in "fewer, bigger, bolder, and faster bets" is driving stronger growth momentum for Marico believes the brokearge.

In retail-led real estate, Phoenix Mills continued to be rated Buy with an unchanged target price of Rs 2,104, supported by strong consumption trends, mall expansion and office leasing growth.

Among other stocks, the brokerage has retained a Buy rating on Sun Pharma with a revised target price of Rs 2,180, citing steady India business growth and expectations of recovery in its specialty portfolio.

Based on the market prices in the report, PNC Infratech offers the highest target-implied upside of up to 75%, followed by Ambuja Cements at 55% and Symphony at 54%.

The company aims to raise Rs 183.1 crore through a fresh issue of about 2.23 crore equity shares. There is no offer-for-sale component, meaning the entire issue proceeds will go to the company.

Based on the share prices cited in this report, MedPlus Health Services offers the highest target-implied upside of up to 44%, followed by Route Mobile at 40% and Tanla Platforms at 36%.

HDFC Securities has reviewed the quarterly performance of seven companies across infrastructure, insurance, financial services, defence, cement, chemicals and technology, assessing their earnings, growth outlook and valuations.

For Dalmia Bharat, the brokerage continued with a Buy recommendation but reduced the target price to Rs 2,030 from Rs 2,110, citing pressure on margins and costs.

HDFC Securities has reviewed the Q2 FY27 performance of nine companies, including Infosys, Shriram Finance, SBI Cards, IndusInd Bank, DCB Bank, Torrent Pharma, Dr. Reddy's Labs, HPCL and Godrej Properties, retaining its existing ratings across all 9 stocks while revising target prices for eight.

HDFC Securities has released its latest Q2 FY27 earnings review, sharing its outlook on SRF, Havells, Cyient, CreditAccess Grameen To Mahindra Lifespaces. The brokerage has assessed the companies' quarterly performance, growth prospects and key risks, while revisiting its stock ratings, target prices and earnings estimates following the September-quarter results.

HDFC Securities has maintained its positive stance on all the three stocks, even as the brokerage revised its target prices for two of the three stocks.

Following the quarterly numbers of UltraTech Cement, Union Bank of India, Bajaj Finance, Piramal Finance, L&T Tech, Sobha, Shoppers Stop, the brokerage reviewed its outlook on the companies, factoring in their growth prospects, profitability trends and near-term challenges while accessing its ratings across the pack

Angel One, L&T Finance, LTM and Federal Bank are in focus after their Q2 FY27 earnings as HDFC Securities sees further upside across the four stocks.

Wipro, Tech Mahindra, Indian Bank and Persistent Systems are among the stocks for which HDFC Securities has raised its target prices following the September-quarter earnings season.